Genta, Inc. (GNTA) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genta, Inc. (GNTA)

GNTA 2.300

+0.4%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tom pope who wrote (1824)	6/1/2004 9:21:38 PM
From: Art Bechhoefer	Read Replies (1) of 1870

The bias that may have been introduced by testing the control group earlier could have been a basis for the lawsuits filed recently against GNTA. Did the company intentionally give the control group less chance to show improvement than the group taking the combination of genasense and the chemo? If so, the company has deceived investors. On the other hand, the company could simply have done fairly sloppy testing. That is not unheard of either. As for the large sales by a fund set up in the Cayman Islands, I'm not impressed. Investors may set up accounts in the Cayman Islands as a tax shelter. If there are no profits to shelter, then there is little incentive to maintain a position in the stock. I'm trying to get more info from GNTA. Art

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next